Skip to main content
. 2021 Dec 2;13(23):6088. doi: 10.3390/cancers13236088
CAF Cancer-associated fibroblast
CAM Cell adhesion molecule
Cath-E Cathepsin-E
CA19.9 Carbohydrate antigen 19.9
CDCP1 CUB domain-containing protein1
Ce-CT Contrast-enhanced Computed Tomography
CEA Carcinoembryonic antigen
EGFR Epidermoid growth factor receptor
EpCAM Epithelial cell adhesion molecule
ESMO European Society of Medical Oncology
FAP Fibroblast-activating protein
FAPI Fibroblast-activating protein inhibitor
FAZA Fluoroazomycin arabinoside
FDG Fluorodeoxyglucose
FGS Fluorescence-guided surgery
FLT Fluorothymidine
FMISO Fluoromisonidazole
GRP78 Glucose-regulating protein-78
LAPC Locally-advanced pancreatic cancer
mAb Monoclonal antibody
MMP Matrix metalloproteinase
MRI Magnetic resonance imaging
NCCN National Comprehensive Cancer Network
NET Neuro endocrine tumor
NIR Near infrared
NIRF Near infrared fluorescence
NPT Normal pancreatic tissue
NT Neoadjuvant therapy
NTS Neurotensin
NTSR-1 Neurotensin receptor-1
OS Overall survival
PDAC Pancreatic ductal adenocarcinoma
PSMA Prostate membrane antigen
PET Positron emission tomography
scFv Single-chain variable fragment
SPECT Single-photon emission computed tomography
SMI Small molecule inhibitor
SUV Standardized uptake value
TfR1 Transferrin receptor-1
TBR Tumor-to-background ratio
TF Tissue Factor
uPA Urokinase-type plasminogen activator
uPAR Urokinase-type plasminogen activator Receptor
VEGFR Vascular endothelial growth factor receptor
VEGF-A Vascular endothelial growth factor A
WLI White light inspection